Accounts receivable, net of allowances of 110,871 and 69,641 as of june 30, 2026 and december 31, 2025, respectively
257,729
248,387
217,263
274,200
Inventory, net of allowances of 40,000 and 0 as of june 30, 2026 and december 31, 2025, respectively
251,290
224,555
225,253
191,762
Prepaid expenses and other current assets
360,801
356,764
241,145
314,952
Total current assets
4,602,765
5,734,161
2,761,503
1,136,805
Property and equipment, net
832,851
474,641
386,165
405,417
Lease right of use
2,151,844
1,976,210
1,286,217
2,096,739
Intangible assets, net
1,359,445
1,369,795
1,325,145
1,430,495
Goodwill
9,251,563
6,519,232
5,878,986
5,878,986
Equity investments
-
-
-
613,771
Investment in naya therapeutics
2,466,810
2,466,810
2,466,810
2,466,810
Note receivable
5,169,284
5,029,770
5,029,770
4,803,175
Note receivable-Related Party
-
1,085,528
1,085,528
-
Total assets
25,834,562
24,656,147
20,220,124
18,832,198
Current liabilities held for sale
-
-
-
0
Accounts payable and accrued liabilities
1,601,018
1,668,216
2,034,057
2,391,222
Accrued compensation
450,141
349,957
285,946
342,957
Convertible notes payable-Nonrelated Party
-
-
-
149,293
Notes payable-Nonrelated Party
505,298
362,567
1,054,664
-
Convertible notes payable-Related Party
-
-
-
880,000
Notes payable-Related Party
621,389
880,000
220,000
-
Deferred revenue
788,498
725,493
721,897
720,407
Lease liability, current portion
407,568
271,793
208,987
265,808
Additional payments for acquisition, current portion
2,098,000
2,050,000
3,925,000
4,484,500
Derivative liability
-
-
1,881,078
-
Other current liabilities
47,812
47,812
-
10,500
Total current liabilities
6,519,724
6,355,838
10,331,629
9,244,687
Lease liability, net of current portion
1,874,057
1,810,504
1,171,075
1,987,121
Liability for excess losses of equity method investee
-
426,306
448,474
-
Notes payable net of current portion
513,386
660,165
744,725
951,668
Deferred tax liability
56,129
-
-
-
Other liabilities, net of current portion
79,688
79,688
-
-
Additional payments for acquisition, net of current portion
300,000
300,000
300,000
800,000
Total liabilities
9,342,984
9,632,501
12,995,903
12,983,476
Preferred stock value-Series COne Preferred Stock
-
-
-
0
Preferred stock value
-
-
2,406,359
8,877,359
Preferred stock, value
400,000
400,000
-
-
Common stock, .0001 par value 50,000,000 shares authorized 2,295,035 and 477,366 issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
229
164
239
542
Additional paid-in capital
112,126,967
111,547,840
96,187,026
90,063,124
Accumulated deficit
-96,035,618
-96,924,358
-91,369,403
-93,092,303
Total stockholders equity
16,491,578
15,023,646
7,224,221
5,848,722
Total liabilities and stockholders equity
25,834,562
24,656,147
20,220,124
18,832,198
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.